IPP Bureau
Narayana Hrudayalaya to open a hospital in Punjab
By IPP Bureau - December 05, 2021
The hospital is scheduled to open in 2024 with a bed capacity of 225
Lupin and Biomm tie-up for pegfilgrastim in Brazil
By IPP Bureau - December 05, 2021
Lupin had earlier received the U.S. FDA acceptance of the Biologics License Application (BLA) for Its proposed biosimilar
SPARC to licence Biomodifying’s IP
By IPP Bureau - December 05, 2021
SPARC will pay Biomodifying a percentage of payments received for sublicenses of the licensed IP
Morpen gets U.S. FDA approval for Fexofinadine
By IPP Bureau - December 05, 2021
Fexofinadine is the most widely used, second-generation antihistamine drug for the treatment of allergy symptoms and hay fever
Apollo Health Ventures closes US $ 180 million fund
By IPP Bureau - December 05, 2021
The fund aims at investing in companies that extends human healthspan
Motherhood Hospitals opens second center in Pune
By IPP Bureau - December 05, 2021
The first hospital in Kharadi launched three years ago has made a significant difference to women and children's health
Monthly production capacity of Covishield and Covaxin touches 90% : Govt
By IPP Bureau - December 05, 2021
Serum has a capacity of 250-275 million whereas Bharat Biotech has a capacity of 50-60 million
Unichem Labs gets ANDA approval for schizophrenia medicine
By IPP Bureau - December 03, 2021
The product will be commercialized from Unichem's Ghaziabad plant
Biocon Pharma receives ANDA approval for Mycophenolic acid
By IPP Bureau - December 03, 2021
This further adds to Biocon’s portfolio of vertically integrated complex drug products
Novartis showcases its attractive growth pipeline
By IPP Bureau - December 03, 2021
Focused medicines company delivering strong operational performance. Building depth in five core therapeutic areas, strength in technology platforms, and a balanced geographic footprint
North America accounts for 50 % of generic pharma market
By IPP Bureau - December 03, 2021
Going forward, the fastest-growing regions in the generic pharmaceuticals market will be South America and the Middle East, where growth will be at CAGRs of 10.1% and 9.4% respectively
Neuberg Diagnostics expands to North India
By IPP Bureau - December 03, 2021
Collectively, these 10 laboratories are capable of processing about 10,000 samples in a day and deliver results within the given turnaround time
Over one lakh SARS-CoV-2 genomes sequenced till November
By IPP Bureau - December 03, 2021
Union Minister Dr Jitendra Singh said a large number of Covid-19 bio-repositories and samples were made available to academia and industry
Aster Volunteers offer free diabetes screening in India and UAE
By IPP Bureau - December 03, 2021
In 2019, diabetes was the ninth leading cause of death with an estimated 1.5 million deaths directly caused by diabetes, as per WHO
Booster dose for those above 40
By IPP Bureau - December 03, 2021
The recommendation was made by the Indian SARS-CoV-2 Genomics Sequencing Consortium (INSACOG), a network of national testing labs set up by the government to monitor genomic variations of Covid-19
